您的购物车当前为空
别名 昔妥珠单抗, LY3012211, LY 3012211, IMC-11F8, IMC11F8
Necitumumab (IMC-11F8) 是一种针对表皮生长因子 (EGF) 受体的人单克隆抗体,是一种用于治疗晚期非小细胞肺癌的抗血管生成剂,可用于研究癌症。

为众多的药物研发团队赋能,
让新药发现更简单!
Necitumumab (IMC-11F8) 是一种针对表皮生长因子 (EGF) 受体的人单克隆抗体,是一种用于治疗晚期非小细胞肺癌的抗血管生成剂,可用于研究癌症。
| 规格 | 价格 | 库存 | 数量 |
|---|---|---|---|
| 1 mg | ¥ 993 | In stock | |
| 5 mg | ¥ 2,880 | In stock | |
| 10 mg | ¥ 4,970 | In stock | |
| 25 mg | ¥ 7,570 | In stock | |
| 50 mg | ¥ 9,870 | In stock |
Necitumumab 相关产品
| 产品描述 | Necitumumab (IMC-11F8) is a human monoclonal antibody directed against the epidermal growth factor (EGF) receptor, an anti-angiogenic agent used in the treatment of advanced non-small cell lung cancer, and may be used in cancer research. |
| 别名 | 昔妥珠单抗, LY3012211, LY 3012211, IMC-11F8, IMC11F8 |
| 分子量 | 145.5 kDa |
| CAS No. | 906805-06-9 |
| 存储 | store at low temperature | -20°C for 1 year | Shipping with blue ice/Shipping at ambient temperature. |
评论内容